Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 4/20 | 0.72 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.72 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.72 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.72 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | HTR2C | P28335 | 2/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | HRH1 | P35367 | 1/20 | 0.72 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.72 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anisodamine SCHEMBL30317064 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL29353530 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL30679509 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL31098813 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL28725258 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL620576 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Anisodamine SCHEMBL30679510 | 1.00 | CHRM1 (0.72) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| SCHEMBL16167837 | 0.84 | CHRM1 (0.76) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Atropine SCHEMBL8854381 | 0.84 | CHRM1 (1.00) | CHRM1CHRM2CHRM5CHRM3CHRM4 | |
| Atropine SCHEMBL41317 | 0.84 | CHRM1 (1.00) | CHRM1CHRM2CHRM5CHRM3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | disclosed |
| CN-114414679-B | Method for detecting belladonna alkaloid in animal tissues | 吉林省农业科学院 | 2024-05-07 | — | — | CN | disclosed |
| CN-117379367-A | Ophthalmic pharmaceutical composition | 艾尔健康眼药(辽宁)有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-113662915-B | Ophthalmic pharmaceutical composition | 艾尔健康眼药(辽宁)有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-113527286-B | Method for separating and purifying anisodamine monomer from alkaloid extract | 锦州拾正生物科技有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-113440486-B | An eye drop composition for preventing or treating ophthalmic diseases, and its preparation method | 苏州欧康维视生物科技有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-114414679-A | Method for detecting belladonna alkaloid in animal tissue | 吉林省农业科学院 | 2022-04-29 | — | — | CN | disclosed |
| CN-114276342-A | Method for separating and purifying anisodamine monomer from plant extract | 锦州拾正生物科技有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-113662915-A | Medicinal composition for eyes | 艾尔健康医药(辽宁)有限公司 | 2021-11-19 | — | — | CN | disclosed |
| CN-113527286-A | Method for separating and purifying anisodamine monomer from alkaloid leaching paste | 锦州拾正生物科技有限公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-113440486-A | An eye drop composition for preventing or treating ophthalmic diseases, and its preparation method | 苏州欧康维视生物科技有限公司 | 2021-09-28 | — | — | CN | disclosed |
| CN-111821259-A | Medicinal composition for eyes | 艾尔健康眼药(辽宁)有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-105616893-A | Compound preparation for preventing and improving trigeminal neuroma and preparation method thereof | QING HUIBIN | 2016-06-01 | — | — | CN | disclosed |
| CN-105194237-A | Composition for treating lymphoma and preparation method of composition | LI XIAO | 2015-12-30 | — | — | CN | disclosed |
| CN-104707030-A | Traditional Chinese medicine pills for treating esophageal cancer and preparation method thereof | CAO YANXIN | 2015-06-17 | — | — | CN | disclosed |
| CN-104547250-A | Traditional Chinese medicine composition for inhibiting cancer cell proliferation and preparation method of traditional Chinese medicine composition | GUO LIANGSU | 2015-04-29 | — | — | CN | disclosed |
| CN-104208360-A | Traditional Chinese medicine medicated bath for pruritus eczema and preparation method thereof | JING YING | 2014-12-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | COL2A1, COLGALT1, PLOD3 | CHRM1 1604/4885CHRM2 880/4885CHRM5 2064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.